Tech Company Financing Transactions
Semnur Pharmaceuticals Funding Round
Canaan Partners, Frazier Healthcare Partners and Vivo Capital participated in a $10 million funding round for Semnur Pharmaceuticals. The financing round closed on 3/31/2015.
Transaction Overview
Company Name
Announced On
3/31/2015
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4970 El Camino Real 205
Los Altos, CA 94022
USA
Los Altos, CA 94022
USA
Phone
Website
Email Address
Not Recorded
Overview
Semnur Pharmaceuticals, Inc. is an emerging specialty pharmaceutical company focused on the clinical and commercial development of innovative products that meet the needs of pain management practitioners and their patients.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jaisim Shah
Co-Founder
Mahendra Shah
Browse more venture capital transactions:
Prev: 3/31/2015: Fancy Hands venture capital transaction
Next: 3/31/2015: Maestro Health venture capital transaction
Share this article
News on VC Transactions
We report on all VC transactions involving tech companies. VC investment data records reported here are derived from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs